尿激酶联合颅内微创血肿清除术对高血压脑出血分析  

To analysis the Urokinase combined with minimally invasive intracerebral hematoma removal for hypertensive cerebral hemorrhage patients

作　　者：吴宝东[1] WU Bao-dong(Sixian People＇s Hospital, Sixian 234300, Anhu)

机构地区：[1]泗县人民医院,安徽泗县234300

出　　处：《安徽卫生职业技术学院学报》2018年第2期54-55,共2页Journal of Anhui Health Vocational & Technical College

摘　　要：目的:探讨尿激酶联合颅内微创血肿清除术治疗高血压脑出血的临床疗效。方法:选取高血压脑出血患者40例,将其设定为观察组,并取同时期收治的接受保守治疗的高血压脑出血患者30例,将其设定为对照组。比较两组患者的临床治疗效果。结果:经过治疗后,相较于对照组,观察组的治疗总有效率以及Barthel更高(P<0.05),神经功能缺损评分更低(P<0.05)。结论:尿激酶联合颅内微创血肿清除术可有效治疗高血压脑出血,促使患者的疾病转归得以改善。Objective：To investigate the clinical effects of Urokinase combined with minimally invasive intracerebral hematoma removal in the treatment of hypertensive intracerebral hemorrhage patients. Methods：40 cases of hypertensive intracerebral hemorrhage patients were selected as the observation group,30 cases of hypertensive intracerebral hemorrhage patients who received conservative treatment in the same period were selected as the control group, compared the clinical effects of the two groups. Results： After treatment, compared with the control group, the total effective rate, Barthel of the observation group were higher（P〈0.05）, and the neurological impairment score were lower（P〈0.05）. Conclusion： Urokinase combined with minimally invasive intracerebral hematoma removal can be effective in the treatment of hypertensive intracerebral hemorrhage patients, and improve the patient＇s disease outcome.

关 键 词：高血压脑出血 尿激酶 颅内微创血肿清除术 

分 类 号：R743.34[医药卫生—神经病学与精神病学]